Study JR OÜ
RegisteredKey figures
Ratios
2025Summary: Study JR OÜ
What kind of company is it?
Study JR OÜ (registry code 12631183) is a private limited company (OÜ). The company was entered in the Commercial Register in 2014 and has been registered for 12 years. Registered location: Haabersti linnaosa, Tallinn, Harju maakond. According to the latest annual report, the main activity is specialist medical care (EMTAK 86221). The company is registered for VAT (VAT number EE101718042).
How is the company doing financially?
Revenue in financial year 2025 was 142 971 €, down 2,3% on the previous year (146 408 €). From 2019 to 2025, revenue declined by an average of 4,1% per year. Net profit for financial year 2025 was 18 266 € (12,8% of revenue). The company was profitable in 6 of the 7 published financial years. In financial year 2025 the company had 1 employees. Revenue per employee was 142 971 €. At the end of financial year 2025, total assets were 162 851 € and equity 162 417 € (99,7% of assets).
What do the latest quarters show?
According to the Tax and Customs Board, the company declared no turnover in Q3 2026.
Who runs the company and who owns it?
The company has one management board member. The sole owner of the company is a private individual.
Where does the data come from and how fresh is it?
Register data (name, address, legal form, management board and owners) come from the Commercial Register of the Centre of Registers and Information Systems (RIK); changes are read from RIK every night. Financial figures come from annual reports; the latest report (financial year 2025) was filed on 20.06.2026. Quarterly turnover, employee numbers and labour taxes come from the open data of the Tax and Customs Board (EMTA); latest quarter Q3 2026. Changes, averages and ratios are calculated by entity.ee from open data and are not an official assessment.
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q3 2026 | 0 € | 6 | 384 € |
| Q2 2026 | 2925 € | 6 | 1574 € |
| Q1 2026 | 2145 € | 6 | 324 € |
| Q4 2025 | 2535 € | 6 | 1209 € |
| Q3 2025 | 21 868 € | 6 | 413 € |
| Q2 2025 | 27 103 € | 6 | 992 € |
| Q1 2025 | 1105 € | 6 | 1424 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Dividends
calculatedDistributed as dividends 15 000 € (10% of distributable profit).
Summary of financial statements2021–2025
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Sales revenue | 35 164 | 92 770 | 122 840 | 146 408 | 142 971 |
| Net profit | −33 176 | 2598 | 11 488 | 13 844 | 18 266 |
| Retained earnings | 241 647 | 168 471 | 171 069 | 142 557 | 141 401 |
| Total assets | 211 434 | 175 921 | 187 020 | 160 149 | 162 851 |
| Total liabilities | 213 | 2102 | 1713 | 998 | 434 |
| Total equity | 211 221 | 173 819 | 185 307 | 159 151 | 162 417 |
| Employees | 1 | 1 | 1 | 1 | 1 |
| Average gross salary (monthly) | — | — | — | — | — |
| Calculated dividend | 0 | 40 000 | 0 | 40 000 | 15 000 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Risks and obligationsAll clear
Data from public registers, not a credit rating.
Connections graph
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Related companies
- Aktsiaselts Ida-Tallinna Keskhaigla178 m €
- Aktsiaselts Lääne-Tallinna Keskhaigla122 m €
- Meliva AS56,0 m €
- SYNLAB Eesti OÜ41,9 m €
- AS Arstikeskus Confido39,1 m €